Trexquant Investment LP Decreases Position in ICU Medical, Inc. (NASDAQ:ICUI)

Trexquant Investment LP lessened its position in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 56.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 16,117 shares of the medical instruments supplier's stock after selling 20,869 shares during the period. Trexquant Investment LP owned 0.07% of ICU Medical worth $2,501,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Arizona State Retirement System boosted its holdings in shares of ICU Medical by 1.0% during the fourth quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier's stock worth $1,044,000 after purchasing an additional 65 shares during the period. Equitable Trust Co. lifted its holdings in ICU Medical by 1.6% in the 4th quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier's stock worth $822,000 after buying an additional 84 shares during the period. LPL Financial LLC grew its position in shares of ICU Medical by 2.0% in the 4th quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier's stock worth $747,000 after buying an additional 93 shares during the last quarter. Alliancebernstein L.P. increased its stake in shares of ICU Medical by 0.5% during the fourth quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier's stock valued at $4,051,000 after buying an additional 136 shares during the period. Finally, Gagnon Securities LLC raised its holdings in shares of ICU Medical by 0.5% during the fourth quarter. Gagnon Securities LLC now owns 28,881 shares of the medical instruments supplier's stock valued at $4,481,000 after acquiring an additional 137 shares in the last quarter. Hedge funds and other institutional investors own 96.10% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

Several analysts recently weighed in on ICUI shares. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a report on Tuesday. Raymond James set a $97.00 target price on shares of ICU Medical in a research note on Wednesday, March 12th. Finally, StockNews.com raised shares of ICU Medical from a "hold" rating to a "buy" rating in a research note on Friday, April 4th. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus target price of $168.67.

ICU Medical Stock Up 3.0 %

Shares of ICUI stock traded up $4.22 during mid-day trading on Friday, reaching $142.65. 318,377 shares of the company's stock traded hands, compared to its average volume of 269,086. The company's 50-day moving average price is $148.29 and its 200-day moving average price is $160.95. The company has a market cap of $3.50 billion, a P/E ratio of -31.21 and a beta of 0.86. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a 12 month low of $93.36 and a 12 month high of $196.26.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.